Allurion Technologies (ALUR) said Wednesday it expects to raise roughly $6.1 million from a registered direct share offering to institutional investors.
The company said it signed deals to sell 900,000 shares at $5.23 apiece to the investors. It will also issue warrants to the investors to buy up to 1.8 million shares.
Allurion also said it struck a deal to sell 267,686 shares and warrants to purchase up to 535,372 shares at $5.23 per share and accompanying warrant to funds affiliated with Leavitt Equity Partners.
Proceeds will be used to fund its pipeline evaluating the effects of the combination of the Allurion Balloon and GLP-1 therapy on muscle mass and long-term GLP-1 adherence, for working capital, and for general corporate purposes, the company said.
The offering is expected to close on Thursday, it said.
The shares were down more than 30% in recent trading.
Price: 3.86, Change: -1.72, Percent Change: -30.88
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。